sIgA immunotherapy (Secretory IgA)

N/A

Report date: 2025/01/26 15:34:36

Base Information

Drug NamesIgA immunotherapy (Secretory IgA)
Drug Alias NameSecretory immunoglobulin A (Secretory IgA Inc)
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionToxin A inhibitorsToxin B inhibitors
TargetsToxin BToxin A
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSecretory IgA Inc
China Registration ClassN/A

Develop Information

Active CompaniesSecretory IgA Inc
Inactive CompaniesN/A
Active IndicationsClostridium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A